NMTC
Neuroone Medical Technologies Corp
NASDAQ: NMTC · HEALTHCARE · MEDICAL DEVICES
$4.70
+0.00% today
Updated 2026-04-30
Market cap
$38.95M
P/E ratio
—
P/S ratio
3.32x
EPS (TTM)
$-1.08
Dividend yield
—
52W range
$3 – $7
Volume
0.2M
Neuroone Medical Technologies Corp (NMTC) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $6177.00 | $-5092.00 | $-27428.00 | $-13733.00 | $-13733.00 | $-25093.00 | $-26173.00 | $-30229.00 | $-21106.00 | $-2.83M | $-5.40M | $-3.43M | $-8.60M | $-7.52M | $-12.89M | $-11.01M | $-3.14M |
| Capital expenditures | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $58352.00 | $91709.00 | $91709.00 | $123352.00 | $122427.00 | $67079.00 | $275226.00 | $384117.00 | $120197.00 | $81742.00 |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | — | — | — | — | — | — | — | — | — | $486120.00 | $491749.00 | $1.84M | $1.79M | $947212.00 | $1.11M | $1.34M | $1.26M |
| Free cash flow | $6177.00 | $-5092.00 | $-27428.00 | $-13733.00 | $-13733.00 | $-25093.00 | $-26173.00 | $-88581.00 | $-112815.00 | $-2.92M | $-5.52M | $-3.55M | $-8.67M | $-7.79M | $-13.27M | $-11.13M | $-3.22M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | $0.00 | $0.00 | $0.00 | $0.00 | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | $0.00 | $0.00 | $0.00 | $0.00 | — | — | — | — | — | — | — |